The global plasma expanders market is witnessing a significant growth over the past few years. Plasma expanders are blood volume replacement fluids used during surgery or trauma to increase intravascular volume of circulating blood and effective circulating volume. They prevent or treat hypovolemic shock by expanding blood plasma on an emergency basis in case when transfusion of blood products is not feasible. Some common plasma expanders include albumin, dextran, hydroxyethyl starch, and gelatin. Growth of this market can be attributed to growing number of surgical procedures, trauma and accident cases, rising geriatric population, and increase in chronic diseases. However, factors such as side effects associated with plasma expanders and high costs of treatment may hamper the market growth.
Market Dynamics
Global plasma expander market is primarily driven by the growing prevalence of trauma, burns, and surgical procedures that often involve significant blood loss. According to the World Health Organization (WHO), over 4.5 MN people suffer fatal injuries annually worldwide. Road accidents, violence, wars, and other such causes have contributed to rising trauma cases. Moreover, according to the American Burn Association, over 450,000 burn injuries are treated in specialized American burn centers each year. Plasma expanders form an integral part of the management of hemorrhagic shock in such conditions. However, factors such as the high costs of synthetic colloids and side effects with excessive or prolonged use restrain the market growth. On the other hand, ongoing research on new plasma expander formulations presents an opportunity for market expansion over the forecast period.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook